Search Results 1181-1190 of 13929 for Assay

1. Matthew J. Schellenberg, Ph.D. - Mayo Clinic Faculty Profiles

   In vitro assays to evaluate repair capacity of tumors. Dr. Schellenberg uses the latest techniques in recombinant protein expression and biological ...

2. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

   ... assay demonstrating a high tumor mutation burden (≥ 10 mutations/Mb) and/or a high fraction of ultraviolet (UV) related mutations (> 50% of mutations ...

3. Study To Evaluate The Effectiveness And Safety Of Remdesivir In Participants With Severely Reduced Kidney Function Who Are Hospitalized For Coronavirus Disease 2019 - Mayo Clinic

   ... assay (e.g., Nucleic Acid Amplification Test [NAAT] and antigen tests) in any respiratory specimen. Hospitalized for COVID-19. Age ≥ 12 years and weighing ...

4. Study Of GS-5290 In Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   Participation eligibility · A negative QuantiFERON test or equivalent assay reported by the central laboratory at screening or within 90 days prior to ...

5. A Study To Compare Venetoclax With Fulvestrant Vs. Fulvestrant Alone In Women With Locally Advanced Or Metastatic HER2-negative Cancer Who Have Progressed Or Recurred On A CDK4/6 Inhibitor - Mayo Clinic

   Patients who have a positive HCV antibody test are eligible for the study if a PCR assay is negative for HCV RNA. History of other malignancies within the ...

6. Asthma Clinical Trials - Mayo Clinic Research

   Elisa Eosinophil Peroxidase Assay vs. Validation of a Lateral Flow in Nasal Samples Scottsdale/Phoenix, AZ. The purpose of this study is to compare lateral ...

7. Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane with or without Chemotherapy in Treating Patients with Invasive RxPONDER Breast Cancer - Mayo Clinic

   ... Assay has not been performed, patients must be willing to submit tissue samples for testing to determine the Recurrence Score value; a representative block ...

8. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

   Note: If the participants' PD-L1 expression has already been assessed using same assay, testing platform, and scoring manual as part of the screening ...

9. Hormone Therapy For Breast Cancer Clinical Trials - Mayo Clinic Research

   The purpose of this study is to recruit 2000 incident cases of primary breast cancer in order to perform laboratory assays to measure frequencies of genetic ...

10. Skin Cancer Clinical Trials - Mayo Clinic Research

    The primary objective of this collaborative study is to collect biospecimens for the evaluation of internally developed assays designed to predict for and ...